Jossi Biedermann

Jossi Biedermann is a Researcher in the Department of Hematology at Erasmus Medical Center (Erasmus MC), Rotterdam, the Netherlands, with a focus on clinical thrombosis and hemostasis research.

His primary research interests include:

• Statin therapy effects on coagulation pathways
• Anticoagulant management in complex clinical scenarios
• Pharmacological interactions in thrombotic disorders
• Randomized clinical trial methodology in hematology
• Vaccine-anticoagulant interactions

Analysis of recent publications (2019-2023) reveals consistent investigation into rosuvastatin's impact on coagulation biomarkers, particularly regarding apolipoproteins, phospholipid activity, and fibrinolytic potential. His work demonstrates strong emphasis on translating clinical trial findings into practical anticoagulation management strategies, especially during the COVID-19 pandemic. The research consistently bridges cardiovascular pharmacology and hematology to address real-world patient safety concerns.

Scientific awards: No awards were documented in the available profile information.

Advising and grants: The profile does not specify any doctoral students supervised or research grants administered, though collaborative work with senior researchers suggests potential mentorship roles within the department.

Labs and teams: Dr. Biedermann operates within the Hematology department's clinical research infrastructure at Erasmus MC, collaborating extensively with thrombosis specialists including F.W.G. Leebeek, M.J.H.A. Kruip, and W.M. Lijfering on multi-center studies, though specific laboratory affiliations are not detailed.